These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC. Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600 [Abstract] [Full Text] [Related]
3. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus. Jia L, Coetzee GA. Cancer Res; 2005 Sep 01; 65(17):8003-8. PubMed ID: 16140973 [Abstract] [Full Text] [Related]
4. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action. Bigler D, Gulding KM, Dann R, Sheabar FZ, Conaway MR, Theodorescu D. Oncogene; 2003 Feb 27; 22(8):1261-72. PubMed ID: 12606954 [Abstract] [Full Text] [Related]
5. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells. Tsui KH, Feng TH, Lin CM, Chang PL, Juang HH. J Androl; 2008 Feb 27; 29(6):661-8. PubMed ID: 18676361 [Abstract] [Full Text] [Related]
6. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer. Hisatake JI, Ikezoe T, Carey M, Holden S, Tomoyasu S, Koeffler HP. Cancer Res; 2000 Oct 01; 60(19):5494-8. PubMed ID: 11034093 [Abstract] [Full Text] [Related]
7. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations. Suzuki S, Tadakuma T, Asano T, Hayakawa M. Cancer Res; 2001 Feb 15; 61(4):1276-9. PubMed ID: 11245419 [Abstract] [Full Text] [Related]
8. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J. Prostate; 2007 Feb 01; 67(2):178-89. PubMed ID: 17044040 [Abstract] [Full Text] [Related]
9. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Mori A, Lehmann S, O'Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH, Kizaki M, Koeffler HP. Cancer Res; 2006 Mar 15; 66(6):3222-9. PubMed ID: 16540674 [Abstract] [Full Text] [Related]
10. Synergistic activation of the androgen receptor by bombesin and low-dose androgen. Dai J, Shen R, Sumitomo M, Stahl R, Navarro D, Gershengorn MC, Nanus DM. Clin Cancer Res; 2002 Jul 15; 8(7):2399-405. PubMed ID: 12114445 [Abstract] [Full Text] [Related]
11. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. Wang LG, Ossowski L, Ferrari AC. Cancer Res; 2001 Oct 15; 61(20):7544-51. PubMed ID: 11606392 [Abstract] [Full Text] [Related]
12. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N. Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430 [Abstract] [Full Text] [Related]
13. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Latham JP, Searle PF, Mautner V, James ND. Cancer Res; 2000 Jan 15; 60(2):334-41. PubMed ID: 10667585 [Abstract] [Full Text] [Related]
14. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA. Mol Cancer Res; 2003 Mar 15; 1(5):385-92. PubMed ID: 12651911 [Abstract] [Full Text] [Related]
15. p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6. Debes JD, Comuzzi B, Schmidt LJ, Dehm SM, Culig Z, Tindall DJ. Cancer Res; 2005 Jul 01; 65(13):5965-73. PubMed ID: 15994976 [Abstract] [Full Text] [Related]
16. Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline. Hsieh JT, Wu HC, Gleave ME, von Eschenbach AC, Chung LW. Cancer Res; 1993 Jun 15; 53(12):2852-7. PubMed ID: 7684949 [Abstract] [Full Text] [Related]
17. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells]. Du YF, Xing YF, Zeng FQ, Lu P, Liu XY, Xiao YJ. Zhonghua Zhong Liu Za Zhi; 2007 Jul 15; 29(7):489-94. PubMed ID: 18069626 [Abstract] [Full Text] [Related]
18. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Horii K, Suzuki Y, Kondo Y, Akimoto M, Nishimura T, Yamabe Y, Sakaue M, Sano T, Kitagawa T, Himeno S, Imura N, Hara S. Mol Cancer Res; 2007 Apr 15; 5(4):383-91. PubMed ID: 17426252 [Abstract] [Full Text] [Related]
19. The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells. Slupianek A, Yerrum S, Safadi FF, Monroy MA. J Cell Physiol; 2010 Aug 15; 224(2):369-75. PubMed ID: 20432434 [Abstract] [Full Text] [Related]